
Results
4
Companies which are more than 50% undervalued based on analyst price target.
4 companies
Formycon
Market Cap: €332.6m
A biotechnology company, develops biosimilar drugs in Germany and Switzerland.
FYB
€18.82
7D
4.3%
1Y
-37.6%
MPH Health Care
Market Cap: €100.6m
An investment company, engages in the healthcare business in Germany.
93M1
€23.90
7D
-1.2%
1Y
33.1%
Novogenia
Market Cap: €80.4m
Manufactures and sells personalized health products in global markets.
7V0
€6.70
7D
3.1%
1Y
-8.2%
Cantourage Group
Market Cap: €70.8m
Operates as a medical cannabis company in Europe and internationally.
HIGH
€5.68
7D
4.8%
1Y
38.9%